Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
Xu P, Chen Z, Phan S, Pickar A, He B.
Xu P, et al.
J Virol. 2014 Mar;88(5):2600-10. doi: 10.1128/JVI.02778-13. Epub 2013 Dec 18.
J Virol. 2014.
PMID: 24352450
Free PMC article.
Previously, we have shown that clinical isolate-based recombinant mumps viruses lacking expression of either the V protein (rMuVdeltaV) or the SH protein (rMuVdeltaSH) are attenuated in a neurovirulence test using newborn rat brains (P. Xu et al., Virology 417:126-1 …
Previously, we have shown that clinical isolate-based recombinant mumps viruses lacking expression of either the V protein (rMuVdeltaV) or t …